Mechanistically, numerous chemotherapy drugs induce tumour cell senescence through the ATR–CHK1 and ATM–CHK2 pathways, activating the senescence‐associated pathways involving p53–p21 and p16–RB (Figure 1).20, 21. Here, ATM is linked to neoplasm.